illustration of a brain divided into 4 puzzle pieces
Why Autism Therapies Have an Evidence Problem
Some experts argue that better trials are needed before putting interventions into practice.
ABOVE: © ISTOCK.COM, tasha vector
Why Autism Therapies Have an Evidence Problem
Why Autism Therapies Have an Evidence Problem

Some experts argue that better trials are needed before putting interventions into practice.

Some experts argue that better trials are needed before putting interventions into practice.

ABOVE: © ISTOCK.COM, tasha vector
therapy
Pain Researcher Quits Academia, Takes Lab Home with Him
Jef Akst | May 1, 2021
After resigning from the University of New England last year, Geoffrey Bove continues to study the effects of massage on rats in a facility he set up in his house.
Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
Rachael Moeller Gorman | Apr 1, 2021
Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Catherine Offord | Aug 11, 2020
Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.
Remdesivir Shows Promise in Largest of Several Clinical Trials
Catherine Offord | Apr 30, 2020
Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.
Blood Pressure Meds Point the Way to Possible COVID-19 Treatment
Ashley Yeager | Apr 2, 2020
There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.
More Cancer Mutations, Better Immunotherapy Outcomes
Catherine Offord | Jan 15, 2019
Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.
US Companies Launch CRISPR Clinical Trial
Catherine Offord | Sep 3, 2018
The Germany-based study will test an ex vivo genome-editing therapy for the inherited blood disorder β-thalassemia.
Resurrecting Smells
The Scientist Staff | Oct 31, 2016
Visit the Monell Chemical Senses Center in Philadelphia, where researchers are striving to find a cure for anosmia, the loss of a sense of smell.
Cognitive Neuroscience Lurking in Art
Kerry Grens | Oct 19, 2015
What can neuroscientists learn from the masters and other artists?